Current filters:


US Appeals Court upholds Lo Loestrin Fe patent

US Appeals Court upholds Lo Loestrin Fe patent


Ireland-headquartered generics major Actavis confirmed that it has prevailed in a court battle over the…

ActavisAmneal PharmaceuticalsGenericsLegalLo LoestrinLupinPatentsReproductiveUSAWomen's Health

US federal judge tells FDA to lift age restrictions on morning-after pill


A US federal judge has ordered the Food and Drug Administration to lift age and other restrictions on…

LegalPharmaceuticalPlan BReproductiveTeva Pharmaceutical IndustriesWomen's Health

Watson settles with Janssen over Ortho Tri-Cyclen LO


US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Pfizer wins case to stop Teva selling generic Viagra in USA


Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Bayer launches orodispersible ED treatment in the UK; hit with gender discrimination suit in USA


Today marks the launch in the UK of German drug major Bayer’s (BAY: DE) Levitra (vardenafil) orodispersible…

BayerEuropeLegalLevitraMarkets & MarketingNorth AmericaPharmaceuticalReproductive

Back to top